These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 9669206)

  • 21. Platelet activation by polymorphonuclear leukocytes exposed to chemotactic agents.
    Del Maschio A; Evangelista V; Rajtar G; Chen ZM; Cerletti C; De Gaetano G
    Am J Physiol; 1990 Mar; 258(3 Pt 2):H870-9. PubMed ID: 2156456
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Formation of a highly stable complex between BN 50730 [tetrahydro-4,7,8,10 methyl-1(chloro-2 phenyl)-6 (methoxy-4 phenyl-carbamoyl)-9 pyrido [4',3'-4,5] thieno [3,2-f] triazolo-1,2,4 [4,3-a] diazepine-1,4] and the platelet-activating factor receptor in rabbit platelet membranes.
    Silva CL; Cruz HN; Violante FA; Cordeiro RS; Martins MA; Noël F
    Biochem Pharmacol; 1996 Jan; 51(2):193-6. PubMed ID: 8615889
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanisms of platelet-activating factor-induced lipid body formation: requisite roles for 5-lipoxygenase and de novo protein synthesis in the compartmentalization of neutrophil lipids.
    Bozza PT; Payne JL; Goulet JL; Weller PF
    J Exp Med; 1996 Apr; 183(4):1515-25. PubMed ID: 8666909
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stimulation of human polymorphonuclear leukocytes by leukotriene B4 and platelet-activating factor: an ultrastructural and pharmacological study.
    Rossi AG; MacIntyre DE; Jones CJ; McMillan RM
    J Leukoc Biol; 1993 Feb; 53(2):117-25. PubMed ID: 8383164
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heterogeneous platelet-activating factor (PAF) receptors and calcium increase in platelets and macrophages.
    Centemeri C; Colli S; Tosarello D; Ciceri P; Nicosia S
    Biochem Pharmacol; 1999 Feb; 57(3):263-71. PubMed ID: 9890553
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of serine proteinase inhibitors on intracellular free calcium rise in human polymorphonuclear leukocytes after stimulation with receptor agonists.
    Nowak D; Król M; Białasiewicz P
    Arch Immunol Ther Exp (Warsz); 1998; 46(2):121-6. PubMed ID: 9613710
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sensitization of human neutrophil defense activities through activation of platelet-activating factor receptors by ginkgolide B, a bioactive component of the Ginkgo biloba extract EGB 761.
    Lenoir M; Pedruzzi E; Rais S; Drieu K; Perianin A
    Biochem Pharmacol; 2002 Apr; 63(7):1241-9. PubMed ID: 11960600
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of leukotriene formation and IL-8 release by the paf-receptor antagonist SM-12502.
    Hilger RA; Köller M; König W
    Inflammation; 1996 Feb; 20(1):57-70. PubMed ID: 8926049
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel action of lignans isolated from Hernandia nymphaeifolia on Ca2+ signaling in human neutrophils.
    Chao YY; Su W; Jan CR; Ko YC; Chen JJ; Cheng JS; Liu CP; Lo YK; Chou KJ; Lee KC; Chen WC; Chen IS
    Arch Toxicol; 2002 Jan; 75(11-12):695-702. PubMed ID: 11876502
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of Y-24180, a platelet-activating factor-receptor antagonist, on the antigen-induced airway microvascular leakage in guinea pigs.
    Iwahisa Y; Yamaguchi S; Kagoshima M; Terasawa M
    Jpn J Pharmacol; 1996 Nov; 72(3):209-15. PubMed ID: 8957681
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel effect of Y-24180, a presumed specific platelet activation factor receptor antagonist, on Ca2+ levels and growth of human prostate cancer cells.
    Jan CR; Chao YY
    Cell Signal; 2004 Aug; 16(8):959-65. PubMed ID: 15157675
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stimulation of intracellular free calcium increases by platelet-activating factor in HT29 colon carcinoma cells. Spectrofluorimetric and preliminary spatio-temporal analysis using confocal laser scanning fluorescence imaging microscopy.
    Lohmeyer M; McNaughton L; Hunt SP; Workman P
    Biochem Pharmacol; 1994 Mar; 47(6):975-85. PubMed ID: 8147917
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacology of a potent platelet-activating factor antagonist: Ro 24-4736.
    Crowley HJ; Yaremko B; Selig WM; Janero DR; Burghardt C; Welton AF; O'Donnell M
    J Pharmacol Exp Ther; 1991 Oct; 259(1):78-85. PubMed ID: 1656030
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Agonist-induced calcium flux, phosphoinositide metabolism, aggregation and enzyme secretion in human neutrophils.
    Rossi AG; McMillan RM; MacIntyre DE
    Agents Actions; 1988 Jul; 24(3-4):272-82. PubMed ID: 2845744
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of PAF-induced platelet aggregation by WEB 2086 'in-vitro', an antagonist to the receptor for platelet-activating factor, in bovine.
    da Silva MB; Herion F; Raskinet R; David JL; Gustin P; Dessy C; Lekeux P
    Zentralbl Veterinarmed A; 1996 Sep; 43(7):399-413. PubMed ID: 8921726
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel effect of Y-24180, a presumed specific platelet-activating factor receptor antagonist, on Ca2+ levels and growth of human osteosarcoma cells.
    Jan CR; Chao YY
    Pharmacol Res; 2005 Mar; 51(3):189-95. PubMed ID: 15661567
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Platelet-activating factor (PAF) receptor-mediated calcium mobilization and phosphoinositide turnover in neurohybrid NG108-15 cells: studies with BN50739, a new PAF antagonist.
    Yue TL; Gleason MM; Gu JL; Lysko PG; Hallenbeck J; Feuerstein G
    J Pharmacol Exp Ther; 1991 Apr; 257(1):374-81. PubMed ID: 1850473
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Leukotriene B4 and platelet activating factor production in permeabilized human neutrophils: role of cytosolic PLA2 in LTB4 and PAF generation.
    Bauldry SA; Wooten RE
    Biochim Biophys Acta; 1996 Sep; 1303(1):63-73. PubMed ID: 8816854
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of WEB 2086-BS, an antagonist of platelet-activating factor receptors, on retinal vascularity in diabetic rats.
    de la Cruz JP; Moreno A; Ruiz-Ruiz MI; García-Campos J; Sánchez de la Cuesta F
    Eur J Pharmacol; 1998 Oct; 360(1):37-42. PubMed ID: 9845270
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhancement of leukotriene B4 release in stimulated asthmatic neutrophils by platelet activating factor.
    Shindo K; Koide K; Fukumura M
    Thorax; 1997 Dec; 52(12):1024-9. PubMed ID: 9516893
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.